Precision medicine in diabetes

Submission status
Submission deadline

Recent years have seen significant strides forward in precision medicine for diabetes, a chronic disease affecting over 400 million people and causing around 2 million deaths per year globally. Precision diabetes medicine aims to exploit the growing volume of clinical and molecular data available to clinicians to optimize patient diagnosis and prognostication, disease prevention, and treatment selection. Patient-tailored prevention and care is being increasingly enabled by an improved understanding of the genetic and environmental contributors to disease risk and progression; emerging highly efficacious therapies; digital technologies to aid glucose control; and a better appreciation of the importance of patient-centered outcomes and quality of life.

This Collection includes a series of systematic reviews published by the ADA/EASD Precision Medicine in Diabetes consortium, where an international network of clinicians and scientists assessed the evidence available in the published peer-reviewed literature on precision diabetes medicine and identified barriers in and opportunities for its implementation. Each systematic review has a different focus on prevention, diagnostics, prognostics or treatment for type 1 diabetes, type 2 diabetes, monogenic diabetes or gestational diabetes mellitus. Evidence collected for the preparation of the systematic reviews was used to support the creation of a consensus report on gaps and opportunities in the clinical translation of precision diabetes medicine, published in Nature Medicine.

The Collection is also open for submissions of primary research on the topic of precision medicine in diabetes, from any authors working in this area. We welcome clinical and translational studies focused on precision prevention, diagnosis, prognosis and treatment of all types of diabetes. Other article types such as Reviews, Perspectives, and Comments that add significant insight will also be considered for inclusion in the Collection. All submissions will be subject to the same review process and editorial standards as regular Communications Medicine Articles.

Submit manuscript
Submission guidelines
Manuscript editing services
A continuous glucose monitoring system

The Collection will publish original research Articles, and Commentary such as Reviews, Perspectives and Comments (full details on content types can be found here). Papers will be published in Communications Medicine as soon as they are accepted and then collected together and promoted on the Collection homepage. Collections are associated with a call for papers and are managed by the journal's Editors.

This Collection welcomes submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of Communications Medicine more generally. See our editorial process page for more details. 

All submissions are subject to the same peer review process and editorial standards as regular Communications Medicine articles, including the journal’s policy on competing interests. See our Collections guidelines for more details. 

This Collection is not supported by sponsorship.